ArticleDiabetes2005

Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals.

Sun H Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.